COPENHAGEN (Reuters) -Shares in Novo Nordisk and Eli Lilly slipped on Friday after both agreed with the U.S government to ...
Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...
Donald Trump has signed deals with the pharma giants Novo Nordisk and Eli Lilly to lower the prices of antiobesity drugs and ...
The list prices of obesity drugs Wegovy and Zepbound are over $1,000, but that's not necessarily what you pay.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback